HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel Boutin Selected Research

globotriaosylceramide (globotriosylceramide)

10/2021Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort.
11/2020Assessing the role of glycosphingolipids in the phenotype severity of Fabry disease mouse model.
12/2017Separation and Analysis of Lactosylceramide, Galabiosylceramide, and Globotriaosylceramide by LC-MS/MS in Urine of Fabry Disease Patients.
3/2017Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation.
1/2017High-Risk Screening for Fabry Disease: Analysis by Tandem Mass Spectrometry of Globotriaosylceramide (Gb3 ) in Urine Collected on Filter Paper.
12/2016Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.
1/2016Tandem Mass Spectrometry Quantitation of Lyso-Gb3 and Six Related Analogs in Plasma for Fabry Disease Patients.
7/2015Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma.
4/2014Multiplex tandem mass spectrometry analysis of novel plasma lyso-Gb₃-related analogues in Fabry disease.
10/2013A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel Boutin Research Topics

Disease

30Fabry Disease (Fabry's Disease)
10/2021 - 03/2012
5Gaucher Disease (Gaucher's Disease)
06/2022 - 01/2020
2Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
05/2022 - 05/2020
2Disease Progression
01/2020 - 11/2018
2Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 01/2019
2Parkinson Disease (Parkinson's Disease)
01/2018 - 02/2016
13-Hydroxyacyl-CoA Dehydrogenase Deficiency
06/2022
1Sphingolipidoses (Sphingolipidosis)
03/2022
1Inborn Errors Metabolism (Inborn Errors of Metabolism)
03/2021
1Inborn Urea Cycle Disorders
03/2021
1Hypertrophy
11/2020
1Mucopolysaccharidoses
11/2019
1Pre-Eclampsia (Preeclampsia)
08/2019
1Mucopolysaccharidosis II (Hunter Syndrome)
04/2019
1Albuminuria
01/2019
1Heart Failure
11/2018
1Inflammation (Inflammations)
11/2018
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
11/2018
1Infarction (Infarctions)
01/2018
1Mucopolysaccharidosis IV (Morquio Syndrome)
02/2016
1Muscle Weakness
01/2016
1Glycogen Storage Disease Type II (Pompe's Disease)
01/2016
1Asthma (Bronchial Asthma)
01/2016
1Cardiomyopathies (Cardiomyopathy)
07/2015
1Heart Diseases (Heart Disease)
07/2015
1Bronchiolitis Obliterans Syndrome
11/2009
1Chronic Obstructive Pulmonary Disease (COPD)
03/2009

Drug/Important Bio-Agent (IBA)

22Biomarkers (Surrogate Marker)IBA
06/2022 - 11/2009
20EnzymesIBA
06/2022 - 12/2012
16GalactosidasesIBA
11/2020 - 03/2012
11globotriaosylceramide (globotriosylceramide)IBA
10/2021 - 12/2012
8globotriaosyl lysosphingolipidIBA
10/2021 - 12/2012
8GlycosphingolipidsIBA
11/2020 - 03/2012
6Biological ProductsIBA
04/2019 - 12/2012
5Protein Isoforms (Isoforms)IBA
11/2020 - 10/2013
4Glucosylceramidase (Glucocerebrosidase)IBA
06/2022 - 02/2016
4SphingolipidsIBA
03/2022 - 01/2016
3alpha-Galactosidase (Beano)IBA
01/2021 - 01/2018
3galabiosylceramideIBA
11/2020 - 01/2016
2CreatinineIBA
06/2022 - 05/2020
2AcidsIBA
06/2022 - 02/2022
2Methylmalonic AcidIBA
05/2022 - 05/2020
2GlycolipidsIBA
03/2022 - 11/2020
2Proteins (Proteins, Gene)FDA Link
08/2019 - 03/2009
1VitaminsIBA
06/2022
1Amino AcidsFDA Link
03/2021
1Glycoproteins (Glycoprotein)IBA
11/2020
1Fatty Acids (Saturated Fatty Acids)IBA
11/2020
1SphingosineIBA
11/2020
1GlycosaminoglycansIBA
11/2019
1podocalyxinIBA
08/2019
1NPHS2 proteinIBA
08/2019
1Dermatan SulfateIBA
04/2019
1Heparitin Sulfate (Heparan Sulfate)IBA
04/2019
1migalastatIBA
01/2019
1agalsidase betaFDA Link
01/2019
1agalsidase alfaIBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2018
1Atrial Natriuretic Factor (ANF)IBA
11/2018
1Interleukin-6 (Interleukin 6)IBA
11/2018
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2018
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2018
1Matrix Metalloproteinases (MMPs)IBA
11/2018
1Galectin 1 (LGALS1)IBA
11/2018
1Galectin 3 (LGALS3)IBA
11/2018
1alpha-SynucleinIBA
01/2018
1CDw17 antigen (lactosylceramide)IBA
12/2017
1Lysergic Acid Diethylamide (LSD)IBA
06/2017
1Galactosylceramides (Galactocerebrosides)IBA
02/2016
1Glucosylceramides (Glucocerebrosides)IBA
02/2016
1DisaccharidesIBA
02/2016
1Keratan SulfateIBA
02/2016
1GlycogenIBA
01/2016
1Fluticasone (Cutivate)FDA LinkGeneric
01/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2016
1pyridinolineIBA
11/2009
1DesmosineIBA
11/2009
1deoxypyridinolineIBA
11/2009
1CreatineIBA
03/2009
1ElastinIBA
03/2009

Therapy/Procedure

3Enzyme Replacement Therapy
09/2020 - 04/2019
2Therapeutics
01/2021 - 01/2019
1Hematopoietic Stem Cell Transplantation
11/2009